Name | Value |
---|---|
Revenues | 5,957.7K |
Cost of Revenue | 3,967.4K |
Gross Profit | 1,990.3K |
Operating Expense | 2,769.7K |
Operating I/L | -779.5K |
Other Income/Expense | 168.9K |
Interest Income | 207.4K |
Pretax | -610.5K |
Income Tax Expense | 41.0K |
Net Income/Loss | -651.5K |
Sunshine Biopharma, Inc. is a pharmaceutical and nutritional supplement company specializing in the research and development of anticancer drugs. Their flagship product, Adva-27a, is designed to treat various forms of cancer and eliminate multidrug resistant cancer cells. Additionally, the company is developing SBFM-PL4, an anti-coronavirus treatment compound. Sunshine Biopharma also offers Essential 9, a nutritional supplement tablet, and Essential Calcium-Vitamin D supplement. They generate revenue through the sale of these science-based nutritional supplements and the potential future commercialization of their anticancer and anti-coronavirus drugs.